日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multi-parametric MRI synthesis for glioblastoma from quantitative MR fingerprinting: Quantitative synthetic neural network (QS-Net)

基于定量磁共振指纹图谱的多参数磁共振成像合成方法用于胶质母细胞瘤:定量合成神经网络(QS-Net)

Ni, Yimin; Liu, Chenyang; Li, Wen; Lin, Ling; Ouyang, Rushan; Cao, Peng; Lee, Ho-Fun Victor; Helali, Aya El; Wong, Yat-Lam; Wang, Xiang; Wang, Peilin; Ren, Ge; Cai, Jing; Li, Tian

Diagnostic Complexity of Recurrent Ascites: Pancreatic Ascites Mimicking Portal Hypertension

复发性腹水的诊断复杂性:胰腺腹水酷似门静脉高压

Grossmann, Idan; Sanekommu, Harshavardhan; Ahsan, Sidra; Angelova, Evgeniya; Peng, Lee

HPV-Negative Basaloid Squamous Cell Carcinoma of the Rectum: An Exceptionally Rare Entity

直肠HPV阴性基底样鳞状细胞癌:一种极其罕见的疾病

Grossmann, Idan; Sanekommu, Harshavardhan; Ahsan, Sidra; Campbell, Natasha; Taneja, Vikas; Peng, Lee; Chinnici, Angelo; Sen, Shuvendu; Hossain, Mohammad

The cerebellum shapes motions by encoding motor frequencies with precision and cross-individual uniformity

小脑通过精确且个体间一致的编码运动频率来塑造运动。

Liu, Chia-Wei; Wang, Yi-Mei; Chen, Shun-Ying; Lu, Liang-Yin; Liang, Ting-Yu; Fang, Ke-Chu; Chen, Peng; Lee, I-Chen; Liu, Wen-Chuan; Kumar, Ami; Kuo, Sheng-Han; Lee, Jye-Chang; Lo, Chung-Chuan; Wu, Shun-Chi; Pan, Ming-Kai

Correspondence to letter to the editor on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial"

致编辑的信函,主题为“基因组生物标志物预测肝细胞癌患者对阿特珠单抗联合贝伐珠单抗免疫疗法的反应:来自IMbrave150试验的启示”

Lee, Sung Hwan; Yim, Sun Young; Kim, Ji Hoon; Lee, Sunyoung S; Kaseb, Ahmed O; Wei, Peng; Lee, Ju-Seog

All-printed chip-less wearable neuromorphic system for multimodal physicochemical health monitoring

用于多模态物理化学健康监测的全印刷无芯片可穿戴神经形态系统

Choi, Yongsuk; Jin, Peng; Lee, Sanghyun; Song, Yu; Tay, Roland Yingjie; Kim, Gwangmook; Yoo, Jounghyun; Han, Hong; Yeom, Jeonghee; Cho, Jeong Ho; Kim, Dong-Hwan; Gao, Wei

Serotonin receptor 5-HT(2A) as a potential target for HCC immunotherapy.

血清素受体 5-HT(2A) 作为 HCC 免疫治疗的潜在靶点

Tay Rong En, Ho Charmaine Min, Ang Nicholas Da Zhi, Tay Hui Chien, Lopez Daniel Z, Na Qiao Rui, Tan Yi Wen, Koh Ser Mei, Tan Kim Peng, Lee Wendy, Lim Jackwee, Lau Maichan, Toh Han Chong, Rotzschke Olaf, Rénia Laurent

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies

NEXUS:一项针对亚洲晚期/转移性实体恶性肿瘤患者的selinexor联合nivolumab和ipilimumab的I期剂量递增研究

R Choo, Joan; Jeraj, Santhiay Nathan; Sundar, Raghav; Yong, Wei Peng; Lee, Matilda; Huang, Yiqing; Asokumaran, Yugarajah; Chan, Gloria H J; Ngoi, Natalie Y L; Wong, Andrea L A; Soo, Ross A; Chee, Cheng Ean; Lim, Joline S J; Goh, Boon Cher; Lee, Soo Chin; Tan, David S P

Targeting Neutrophil-Mediated Inflammation: Identification of Pyrazolidinone Carboxamide Derivatives as Potent Selective Inhibitors of Formyl Peptide Receptor 1 (FPR1)-Activated Neutrophils.

靶向中性粒细胞介导的炎症:鉴定吡唑烷酮羧酰胺衍生物为甲酰肽受体 1 (FPR1) 激活的中性粒细胞的强效选择性抑制剂

Abdel-Halim Mohammad, Wagdy Reem A, Salah Mohamed, Wang Yi-Hsuan, Cheng Tzu-Peng, Lee Yao-Rong, Chen Yu-Cheng, Mandour Yasmine M, Abadi Ashraf H, Engel Matthias, Hwang Tsong-Long

Lesional volume in the prediction of clinically significant prostate cancer

病灶体积在预测临床显著性前列腺癌中的作用

Brodie, Bellamy; Peh, Daniel Yang Yao; Tan, Yu Guang; Law, Yan Mee; Tay, Kae Jack; Cheng, Christopher Wai Sam; Ho, Henry Sun Sien; Yuen, John Shyi Peng; Lee, Alvin Yuan Ming; Chen, Kenneth